Technological Adjuncts for Malignant Brain Tumor Surgery
Faculty speak to malignant brain tumor surgery and its technical adjuncts for neurosurgeons in the operating room. Earn 3.0 CME and learn about the strategies for intraoperative diagnosis and imaging, tumor resection, noninvasive catheter-based treatments as well as how to recognize the validity of emerging techniques in intraoperative brain tumor visualization.
Upon completion of this activity, participants should be able to:
- Apply technological adjuncts that aid in the intraoperative diagnosis and imaging of malignant brain tumors in the operating room during surgery.
- Distinguish technological adjuncts that aid in the resection of malignant brain tumors.
- Demonstrate technological adjuncts that enable noninvasive catheter-based treatments of malignant brain tumors.
- Appraise technological adjuncts that enable minimally invasive, but complete resection, of malignant brain tumors in the operating room.
- Recognize the scientific basis and proposed clinical applications of emerging techniques in intraoperative brain tumor visualization.
The AANS designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.
Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Commercial Support, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.
Please find the relevant financial relationships disclosed below for all individuals in control of content. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial Support.
|Daniel A. Orringer, MD, FAANS||Consultant Fees – Invenio Imaging, Inc., Stryker Stock Shareholder (purchased direct) - Invenio Imaging, Inc., Stryker Inc Board, Trustee, Officer, Leadership position – Stryker Inc|
|Michael A. Vogelbaum, MD, PhD, FAANS||Board, Trustee, Officer, Leadership position – Infuseon Therapeutics, Inc. Honorarium – Tocagen, Celgene|
|Constantinos G. Hadjipanayis, MD, PhD, FAANS||Consultant Fees – Synaptive Inc. Other Financial Support - NX Development Corp|
|Francesco DiMeco, MD, IFAANS||Consultant Fees – Insightec Board, Trustee, Officer, Leadership position - In.tra Stock Shareholder (purchased direct) – Stemgen|
|Andrew E. Sloan, MD, FAANS||Consultant Fees – Monteris Inc., Surgical Theatre Inc. Other Financial Support – Monteris, Inc Honorarium – Surgical Theatre Inc. Stock Shareholder (purchased direct) – Surgical Theatre Inc., Merck Pharmaceuticals, Inc. Grants/Research Support – Lentigen Inc., PharmacoKinesis|
Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.
Manish K. Aghi, MD, PhD, FAANS
Kaisorn Lee Chaichana, MD, FAANS
Alexandra J. Golby, MD, FAANS
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AANS designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was published in 5/19/2020. Credit may be obtained until 5/19/2023.
|Access Date||Quiz Result||Score||Actions|